The document provides an overview of topics and objectives for a CCRN review course covering various cardiovascular and respiratory conditions. It discusses acute coronary syndromes, myocardial infarction, heart blocks, heart failure, aortic aneurysms, cardiomyopathy, shock states, and other conditions. Treatment strategies are outlined for many of these conditions.
1 of 157
Downloaded 214 times
More Related Content
CCRN Review Part 1 (of 2)
1. CCRN REVIEW PART 1
“Never let what you cannot do
interfere with what you can do”
- John Wooden -
Sherry L. Knowles, RN, CCRN, CRNI
3. CCRN REVIEW PART 1
OBJECTIVES
1. Understand the different types of acute coronary syndromes.
2. Identify basic coronary circulation and how it relates to different types
of myocardial infarctions.
3. Anticipate potential complications associated with an AMI.
4. Identify the standard treatment of an AMI.
5. Distinguish between various AV blocks.
6. Recognize the signs & symptoms of heart failure.
7. Identify the treatment of heart failure.
8. Recognize the general definition and classifications of aortic
aneurysms.
9. Understand the different types of aortic dissections.
10. Recognize the signs & symptoms of cardiomyopathy.
11. Differentiate between the different types of cardiomyopathy.
12. Identify the treatment for the different types of cardiomyopathy.
4. CCRN REVIEW PART 1
OBJECTIVES
13. Understand the different stages of shock.
14. Differentiate between different types of shock.
15. Distinguish between arterial and venous peripheral vascular disease.
16. Identify the various treatments for peripheral vascular disease.
17. Define respiratory failure.
18. Identify the various treatments for acute respiratory failure.
19. Recognize the signs & symptoms and causes of various respiratory
alterations.
20. Identify the standard treatment for various respiratory alterations.
21. Explain the common causes of gastrointestinal bleeding.
22. Describe the most commonly seen treatments for GI bleeding.
23. Describe the signs & symptoms of acute pancreatitis and available
treatments.
6. Acute Coronary Syndrome
DEFINITIONS
– Term used to cover a group of symptoms
compatible with acute myocardial ischemia
– Acute myocardial ischemia is insufficient blood
supply to the heart muscle usually resulting from
coronary artery disease
7. Acute Myocardial Infarction
DEFINITION
– Infarction occurs due to mechanical obstruction
of a coronary artery (or branch) caused by a
thrombus, plaque rupture, coronary spasm
and/or dissection.
– STEMI vs. NSTEMI (non-STEMI)
8. Acute Myocardial Infarction
SIGNS & SYMPTOMS
– Complains Vary
May include crushing chest pain (which may or may
not radiate), back, neck, jaw, teeth and/or epigastric
pain, SOB, nausea/vomiting and dizziness
– ST elevations on ECG
– Elevated cardiac enzymes
9. Acute Myocardial Infarction
SIGNS & SYMPTOMS
↑ PAWP, ↓ CO, ↑ SVR, dysrhythmias, S4,
cardiac failure, cardiogenic shock
– Diaphoresis, pallor, referred pains
– Diabetics and women often present abnormal
symptoms
11. 12 Lead ECG
I AVR V1
V4
II AVL V2 V5
III AVF V3 V6
II
V
12. Acute Myocardial Infarction
ST ELEVATIONS
– Anterior Wall MI
Leads V1-V4
Reciprocal changes in leads II, III, and aVF
Area supplied by the LAD
– Inferior Wall MI
Leads II, III and aVF
Reciprocal changes in leads I, and aVL
Area usually supplied by the RCA
13. Acute Myocardial Infarction
ST ELEVATIONS
– Lateral Wall MI
I, aVL, V5 and V6
Area supplied by the Circumflex artery
– Posterior Wall MI
Reflected on the opposite walls
Opposite deflections
18. Acute Myocardial Infarction
NURSING INTERVENTIONS
– O2
– Bedrest
– Serial ECG’s
– Serial cardiac enzymes
– Keep pain free (NTG. MSO4)
– MONA (Morphine, O2, Nitroglycerin, Aspirin),
Heparin, beta-blockers, and ace inhibitors. May also
include thrombolytics or Gp2b3a inhibitors
– PCI, PTCA, IABP, CABG
19. Acute Myocardial Infarction
TREATMENT
– Time Is Heart Muscle
– Prompt ECG
– Goals: Relieve pain, limit the size of the
infarction and to prevent complications
(primarily lethal dysrhythmias)
20. Acute Myocardial Infarction
TREATMENT
– MONA (Morphine, O2, Nitroglycerin, Aspirin),
Heparin, beta-blockers, and ace inhibitors.
May also include thrombolytics or Gp2b3a
inhibitors
– Cardiac Catheterization (with angioplasty,
atherectomy and/or stent)
– IABP, CABG, education
25. Aortic Aneurysms
DEFINITION
– A bulge or ballooning of the aorta
When the walls of the aneurysm include all three
layers of the artery, they are called true aneurysms
When the wall of the aneurysm include only the
outer layer, it is called a pseudo-aneurysm
– May be thoracic or abdominal
27. Aortic Aneurysms Rupture
An aortic aneurysm, depending on its size, may
rupture, causing life-threatening internal bleeding
The risk of an aneurysm rupturing increases as the
aneurysm gets larger
The risk of rupture also depends on the location of
the aneurysm
Each year, approximately 15,000 Americans die of a
ruptured aortic aneurysm.
28. Aortic Aneurysms
CLASSIFICATIONS
– Classified by shape, location along the aorta,
and how they are formed
– May be symmetrical in shape (fusiform) or a
localized weakness of the arterial wall (saccular)
30. Aortic Aneurysms
SIGNS & SYMPTOMS
– Often produces no symptoms
– If an aortic aneurysm suddenly ruptures it presents
with extreme abdominal or back pain, a pulsating
mass in the abdomen, and a drastic drop in blood
pressure
– An increase in the size of an aneurysm means an
increased in the risk of rupture
31. Aortic Aneurysms
THORACIC SIGNS & SYMPTOMS
– Back, shoulder or neck pain
– Cough, due to pressure placed on the trachea
– Hoarseness
– Strider, dyspnea
– Difficulty swallowing
– Swelling in the neck or arms
32. Aortic Dissections
DEFINITION
– Tearing of the inner layer of the aortic wall, which
allows blood to leak into the wall itself and causes
the separation of the inner and outer layers
– Usually associated with severe chest pain radiating
to the back
33. Aortic Dissections
A. Dissection B. Whenever the
beginning in the ascending aorta
ascending aorta is not involved
34. Aortic Dissections
A. Dissection B. Whenever the
beginning in the ascending aorta
ascending aorta is not involved
38. Aortic Aneurysms
TREATMENT
Medical management
– Controlled BP (within specific range)
Surgical repair
> 4.5 cm in Marfan patients or > 5 cm in non-
Marfan patients will require surgical
correction or endovascular stent placement
39. Cardiomyopathy
DEFINITION
– Diseases of the heart muscle that
cause deterioration of the function of
the myocardium
40. Cardiomyopathy
CLASSIFICATIONS
– Primary / Idiopathic (intrinsic)
Heart disease of unknown cause, although viral
infection and autoimmunity are suspected causes
– Secondary (extrinsic)
Heart disease as a result of other systemic diseases,
such as autoimmune diseases, CAD, valvular
disease, severe hypertension, or alcohol abuse
42. Hypertropic Cardiomyopathy
Bizarre hypertrophy of the septum
– Previously called IHSS
Idiopathic Hypertropic Subaortic Stenosis
– Known as HOCM
Hypertropic Obstructive Cardiomyopathy
Positive inotropic drugs Should Not Be Used
↑ Contractility will ↑ outflow tract obstruction
Nitroglycerin Should Not Be Used
– Dilation Will Worsen The Problem
44. Hypertropic Cardiomyopathy
TREATMENT
– Relax the ventricles
Beta Blockers
Calcium Channel Blockers
– Slow the Heart Rate
Increase filling time
– Use Negative Inotropes
Optimize diastolic filling
– Do Not use NTG
Dilation will worsen the problem
45. Restrictive Cardiomyopathy
Rigid Ventricular Wall
– Due to endomyocardial fibrosis
– Obstructs ventricular filling
Least common form
47. Dilated Cardiomyopathy
Grossly dilated ventricles without hypertrophy
– Global left ventricular dysfunction
– Leads to pooling of blood and embolic episodes
– Leads to refractory heart failure
– Leads to papillary muscle dysfunction secondary to
LV dilation
52. Conduction Defects
STABLE VS UNSTABLE
– Stable
Start with medications
– Unstable
Shock (cardioversion or defibrillation)
53. Normal Sinus Rhythm
Heart Rate 60 - 100 bpm
Rhythm Regular
P Wave Before each QRS & identical
PR Interval (in seconds) 0.12 to 0.20
QRS (in seconds) < 0.12
54. Atrial Fibrillation
AFib
– Multifocal atrial impulses at rate 300-600/min
– Irregular conduction to ventricles
55. Atrial Flutter
AFL
– Atrial impulses at rate of 250-350/min
– Regularly blocked impulses at the AV node
– Saw tooth flutter waves
56. Wandering Atrial Pacemaker
WAP
– Multiple ectopic foci in the atria
– Three or more p wave morphologies
– Rate < 100
57. Supraventricular Tachycardia
SVT
– Supraventricular rhythm at rate 150-250
– P waves cannot be positively identified
Atrial Tach = supraventricular rhythm with p wave morphology
that is noticeably different from the sinus p wave
59. Torsades de Pointes
Polymorphic VT
– VT with alternating ventricular focus
– Often associated with prolonged QT Rate < 100
60. Heart Blocks (AV Blocks)
Sinus Rhythm with First Degree AV Block
Sinus Rhythm with Second Degree AV Block, Type 1
Sinus Rhythm with Second Degree AV Block, Type 2
Third Degree AV Block
61. Heart Failure
DEFINITION
– A condition in which the heart cannot pump
sufficient blood to meet the metabolic needs of
the body
– Pulmonary (LVF) and/or systemic (RVF)
congestion is present.
62. Heart Failure
DEFINITION
– Pulmonary Edema
Fluid in the alveolus that impairs gas exchange by
altering the diffusion between alveolus and capillary
Acute left ventricular failure causes cardiogenic
pulmonary edema
Non-cardiogenic pulmonary edema is a synonym for
Adult Respiratory Distress Syndrome (ARDS)
63. Heart Failure
COMPENSATORY MECHANISMS
– Sympaththetic nervous system stimulation
Tachycardia
Vasoconstriction and increased SVR
– Renin-angiotensin-aldosterone system
activation
Hypo perfusion to the kidneys (renin)
Vasoconstriction (angiotension)
Sodium and water retention (kidneys)
Ventricular dilation
64. Heart Failure
FUNCTIONAL CLASSIFICATIONS
– Class I (without noticeable limitations)
– Class II (symptoms upon activity)
– Class III (severe symptoms upon activity)
– Class IV (symptoms at rest)
68. Peripheral Vascular Disease
SYMPTOMS ARTERIAL VENOUS
PAIN Upon walking While standing
PAIN RELIEF On resting, standing or Elevation of extremities
dependent position of lower limbs
EDEMA None Present, edematous
PULSES Decreased or absent May be difficult to palpate
INTEGUMENT Hair loss Brownish pigmentation
Skin shiny May be cyanotic when
CHANGES Nail thickening extremities are dependent
Pallor when elevated
Red when dependent
Ulcers located on toes, lateral Ulcers located on ankles,
ULCERS areas or site of trauma medial or pre-tibial areas
Gangrene possible
SKIN TEMPERATURE Cool Normal or warm
SEXUAL ISSUES Impotency Not present
Sexual dysfunction
69. Peripheral Vascular Disease
TREATMENTS
– Medical
Are they taking ASA, Coumadin, Ticlid, Plavix,
Oral Contraceptives, Hormones?
– Invasive
PTA, atherectomy, stents
– Surgical
Grafts
71. Shock
DEFINITION
– Inadequate perfusion to the body tissues
– Low blood pressure with impaired perfusion
to the end organs
– May result in multiple organ dysfunction
73. Shock
COMPENSATORY MECHANISMS
–Tachycardia
Attempts to deliver more blood to the tissues
–Vasoconstriction
Attempts to maintain adequate BP in order to
adequately perfuse the body tissues
–Increased ADH Secretion
ADH makes the body hold onto water in an effort to
maintain volume and thus enough blood pressure to
perfuse the body tissues
74. Types of Shock
Hypovolemic Shock
– Inadequate perfusion to the tissues due to insufficient intravascular
volume
Cardiogenic Shock
– Inadequate perfusion to the tissues due to heart failure
Distributive Shock
– Inadequate perfusion to the tissues due to blood flow out of the
intravascular space causing insufficient intravascular volume
– Anaphylactic, Septic, and Spinal Shock
Obstructive Shock
– Inadequate perfusion to the tissues due to obstruction of blood flow
81. Obstructive Shock
SIGNS & SYMPTOMS
Low BP Tachycardia
Restlessness Confusion
Agitation (or listless) Pallor
Cool, Clammy Skin ↓ CO , ↓ UOP
Symptoms related to cause
82. Obstructive Shock
CAUSES
Pulmonary Embolus Tamponade
Tension Pneumothorax Aortic Aneurysm
TREATMENT
Treat the Cause
83. Sepsis Syndrome
SIRS Sepsis Severe Septic MODS Death
Infection Sepsis Shock
84. Sepsis Syndrome
Sepsis
– SIRS’ response with presumed/confirmed infection
Severe Sepsis
– Sepsis associated with organ dysfunction, hypoperfusion
(lactic acidosis, oliguria, altered mental status etc.), or
hypotension (SBP < 90 mmHg or ↓ SBP > 40 mmHg)
Septic Shock
– Sepsis with perfusion abnormalities and hypotension
despite adequate fluid resuscitation
85. Septic Shock
EARLY STAGE (Hyperdynamic)
Normal BP Tachycardia
Confusion Agitation (or listless)
↑ Respiratory Rate Temperature
Normal Color Normal or ↑ UOP
Normal PAWP ↑ CO ↓ SVR
LATE STAGE (Hypodynamic)
Low BP Tachycardia
Orthostatic Hypotension Restlessness
Confusion Agitation (or listless)
Thirst Pallor
Cool, Clammy Skin ↓ UOP
↓ CO ↓ PAWP
↓ CVP ↑ SVR
↑ Lactate Levels
87. Treatment for Sepsis
1. Stabilize The Patient
– Fluids (lots of fluids) 150ml/hr or more
– Vasoconstrictors
2. Treat The Cause
– Pan culture, antibiotics
– Seek primary site of infection
– Direct therapy to primary cause
3. Improve Perfusion
– Prevent organ dysfunction
– Treat temp as needed
89. Invasive PA Catheter
Contraindications
Mechanical Tricuspid or Pulmonary Valve
Right Heart Mass (thrombus and/or tumor)
Tricuspid or Pulmonary Valve Endocarditis
90. Basic Concepts
CO = HR X SV
BP = CO x SVR
CO and SVR are inversely related
CO and SVR will change before BP changes
91. Stroke Volume
Components Stroke Volume
– Preload: the volume of blood in the ventricles
at end diastole and the stretch placed on the
muscle fibers
– Afterload: the resistance the ventricles must
overcome to eject it’s volume of blood
– Contractility: the force with which the heart
muscle contracts (myocardial compliance)
95. Normal Hemodynamic Values
Values normalized for body size (BSA)
CI: 2.5 – 4.5 L/min/m2
SVRI: 1970 – 2390 dynes/sec/cm-5/m2
SVI or SI: 35 – 60 mL/beat/m2
EDVI: 60 – 100 mL/m2
96. Mixed Venous Oxygen Saturation
SvO2
End result of O2 delivery and
consumption
Measured in the pulmonary artery
An average estimate of venous saturation for
the whole body.
Does not reflect separate tissue perfusion or
oxygenation
97. Measuring PA Pressures
Measure All Hemodynamic Values
at End-Expiration
– “ Patient Peak”
– “ Vent Valley”
98. Measuring PA Pressures
Measure all pressures at end-expiration
At bottom curve with mechanical ventilator
– “Vent-Valley”
Intrathoracic pressure increases during
positive pressure ventilations (inspiration)
– Positive deflection on waveforms
Intrathoracic pressure decreases during
positive pressure expiration
– Negative deflection on waveforms
102. PAOP Waveform
a-wave
– Atrial contraction
– Correct location for measurement of PAOP
Average the peak & trough of the a-wave
– Begins near the end of QRS or at the QT
segment
Delayed ECG correlation from CVP since PA
catheter is further away from left atrium
103. PAOP Waveform
c-wave
– Rarely present
– Represents mitral valve closure
v-wave
– Represents left atrial filling
– Begins at about the end of the T wave
104. Shock Profiles
Parameter Hypovolemic Cardiogenic Neurogenic Anaphylactic Early Septic Late Septic
CVP/RAP
PAWP or Norm
CO
BP
SVR
HR Norm al
Cardiogenic Shock is the only shock with PAWP
Early (Hyperdynamic) Shock is the only shock with CO and
SVR
Neurogenic Shock is the only shock with bradycardia
Anaphylactic Shock has the definitive characteristic of wheezing due
to bronchospasm
107. ARDS
DEFINITIONS
– Severe respiratory failure associated with pulmonary
infiltrates (similar to infant hyaline membrane disease)
– Pulmonary edema in the absence of fluid overload or
depressed LV function (Non-cardiogenic pulmonary edema)
– Originates from a number of insults involving damage to the
alveolar-capillary membrane
109. ARDS
PATHOPHYSIOLOGY
– Inflammatory mediators are released causing extensive
structural damage
– Increased permeability of pulmonary microvasculature
causes leakage of proteinaceous fluid across the alveolar–
capillary membrane
– Also causes damage to the surfactant-producing type II cells
110. ARDS
CXR CHARACTERISTICS
– Normal size heart
– No pleural effusion
– Ground Glass appearance
– Often normal early in the disease but may rapidly
progress to complete whiteout
114. ARDS
TREATMENT
– Respiratory Support
– PEEP, CPAP
115. Chronic Lung Disease
COPD
– Presents with hyper-inflated lung fields
Due to chronic air trapping
May be barrel chested
– May lead to cor pulmonale (right-sided heart failure)
Due to chronic high pulmonary pressures
– Often hypercarbic (high pCO2)
Often dependent upon hypoxic drive
117. Near Drowning
Salt Water
– Causes body fluids to shift into lungs
Osmosis: From low to high concentration
Results in hemoconcentration & hypovolemia
– Results in acute pulmonary edema
Fresh Water
– Fluids shift into body tissues
Results in hemodilution & hypervolemia
Can result in gross edema
– Damaged alveoli fill with proteinaceous fluid
May lead to pulmonary edema
118. Pneumonia
Lung infection (bacterial, viral, or fungal)
– Most commonly caused by Streptococcus
pneumoniae
Symptoms include fever, pleuretic chest
pain, productive cough, and tachypnea
– Often presents bronchial breath sounds over the
lung area
Treatment involves giving the right antibiotic
119. Pneumothorax
DEFINITIONS
– Simple pneumothorax
Results from buildup of air or pressure in the pleural space
– Spontaneous pneumothorax
May be due to blebs that rupture
The 2 key risk factors are increased chest length and
cigarette smoking
– Tension pneumothorax
Involves a buildup of air in the pleural space due to
one-way movement of air
Progressively worsens
Requires immediate intervention
123. Pneumothorax
SIGNS & SYMPTOMS
– Standard Pneumothorax
Sharp "pleuritic" chest pain, worse on breathing
Sudden shortness of breath
Dry, hacking cough (may occur due to irritation
of the diaphragm)
May cause mediastinal shift
– Tension pneumothorax
Signs of standard pneumothorax with signs of
cardiovascular collapse
Immediately life threatening
May cause mediastinal shift
124. Pneumothorax
TREATMENT
Spontaneous pneumothorax
– Depends on symptoms & size of pneumothorax
– Provide respiratory support
– May need chest tube or needle decompression
Some resolve without intervention
Tension pneumothorax
– Requires immediate intervention
– May cause cardiovascular collapse
– May need chest tube or needle decompression
2nd intercostal space
125. Pneumothorax
TREATMENT
– Pleurodesis
Chemical or surgical adhesion of the lung
to the chest wall
Used for multiple collapsed lungs or
persistent collapse
129. Pulmonary Embolism
Treatment
– Requires immediate intervention
– Provide respiratory support
– Treat pain & comfort
– Usually includes intravenous heparin
Heparin reduces risk of secondary
thrombus formation while clot is reabsorbed
– May require embolectomy
– May require thrombolysis
– May need umbrella filter
– May need long term anticoagulants
130. Respiratory Failure
DEFINITIONS
– Failure to maintain adequate gas exchange
– Inadequate blood oxygenation or CO2
removal
– PaO2 < 50 mmHg
and/or PaCO2 > 50 mmHg
and/or pH <
7.35
on Room Air
137. Respiratory Failure
TREATMENT
– Ensure Adequate Ventilation
↑ FiO2
Ineffective with shunting
Prolonged O2 > 40% causes O2 toxicity
Must use caution with CO2 retainers
– Chronic hypercapnia causes CO2 retainers
to use hypoxic drive
– Too much O2 can depress respirations
142. Gastrointestinal Bleeding
Hematemesis – vomiting of blood (or coffee ground
material) (indicates bleeding above the duodenum )
Melena – passage of black tarry stools > 50ml (indicates
degradation of blood in the bowel)
Hematochezia – passage of red blood (rectal bleeding)
Occult Bleeding – bleeding that is not apparent to the
patient and results from small amounts of blood
Obscure Bleeding – occult or obvious but source not
identified
143. Gastrointestinal Bleeding
Hematemesis – always UGI source
Melana – indicates blood has been in GI tract
for extended periods
– Mostly UGI
– Small bowel
– Rt colon (if bleeding relatively slow)
Hematochezia
– Mostly colon
– Massive UGI bleeding (not enough time for degradation)
144. Gastrointestinal Bleeding
TREATMENT
– Find the underlying cause
– Fluid volume replacement
– Endoscopy or colonoscopy
– Medical and /or surgical therapy
Somatostatin
IV or intra-arterial vasopressin
Sclerotherpay
Angiography with embolization
Electrocoagulation
Band ligation
Balloon tamponade (Sengstaken-Blackmore tube)
145. The Pancreas
The Pancreas secretes digestive enzymes,
bicarbonate, water, and some electrolytes into
the duodenum via the pancreatic duct
– Lipase, Amylase, Trypsin
The Pancreas also produces
and secretes insulin
146. Pancreatitis
DEFINITION
– An autodigestive process resulting
from premature activation of
pancreatic enzymes
147. Pancreatitis
PATHOSHYSIOLOGY
• Inactive pancreatic enzymes are activated outside
of the duodenum
• The swelling pancreas causes fluids to shift into
the retro peritoneum and bowel
• Fluid shifts can cause severe hypovolemia and
hypotension
• Inflammation cause commotion around pancreas
148. Pancreatitis
MANY CAUSES
– Alcoholism – Hypercalcemia
– Biliary Disease – Peptic Ulcer Disease
– Gallstones – Cystic Fibrosis
– Infections – Vascular Disease
– Hyperparathyroidism – Multiple Drugs
– Hypertriglyceridemia – Much Much More
151. Pancreatitis
TREATMENT
– Stabilization – Monitor For Complications
Correct Fluid And – Monitor Blood Sugar
Electrolyte Status
– Respiratory Support – Drug Therapies
– Control Pain Somatostatin,
Demerol Anticholinergics
– NG Tube – Watch For Signs Of
NPO Infection
– TPN – Pray
Restricted Diet
152. Pancreatitis
FULMINATING PANCREATITIS
• Overwhelming form
• Necrotizing form
• Extreme symptoms
• Seen with ESRF patients
• May lead to ARDS & DIC
153. Pancreatitis
FULMINATING PANCREATITIS
• Signs & Symptoms
Tachycardia & low BP (may be the only sign)
Pulmonary & cerebral insufficiency
Acute diabetic ketosis or oliguria
Hemorrhagic pancreatitis may appear
156. References
American Heart Association. (2005). Guidelines 2005 for Cardiopulmonary
Resuscitation and Emergency Cardiovascular Care. Available at:
www.americanheart.org.
Bridges EJ.(2006) Pulmonary artery pressure monitoring: when, how, and what
else to use. AACN Adv Crit Care. 2006;17(3):286–303.
Chulay, M., Burns S. M. (2006). AACN Essentials of Critical Care Nursing.
McGraw-Hill Companies, Inc., Chapter 23.
Finkelmeier, B., Marolda, D. (2004) Aortic Dissection, Journal of Cardiovascular
Nursing: 15(4):15–24.
Hughes E. (2004). Understanding the care of patients with acute pancreatitis.
Nurs Standard: (18) pgs 45-54.
Sole, M. L., Klein, D. G. & Moseley, M. (2008). Introduction to Critical Care
Nursing. 5th ed. Philadelphia, Pa: Saunders.
Thelan, L. A., Urden, L. D., Lough, M. E. (2006). Critical care: Diagnosis and
Treatment for repair of abdominal aortic aneurysm. St. Louis, Mo.:
Mosby/Elsevier. pg 145-188.
157. References Continued
Urden, L., Lough, M. E. & Stacy, K. L. (2009). Thelan's Critical Care Nursing:
Diagnosis and Management (6th ed). St. Louis, Mo.: Mosby/Elsevier.
Woods, S., Sivarajan Froelicher, E. S., & Motzer, S. U. (2004). Cardiac Nursing.
5th ed. Philadelphia, Pa: Lippincott Williams & Wilkins.
Wynne J, Braunwald E. (2004). The Cardiomyopathies in Braunwald's Heart
Disease: A Textbook of Cardiovascular Medicine (7th Edition). Philadelphia:
W.B. Saunders, vol. 2, pps. 1659–1696, 1751–1803.
Zimmerman & Sole. (2001). Critical Care Nursing (3rd Edition). WB Saunders.,
pgs. 41-80, 176-180, 242-266.
Anderson, L. (July 2001). Abdominal Aortic Aneurysm, Journal of
Cardiovascular Nursing:15(4):1–14, July 2001.
Irwin, R. S.; Rippe, J. M. (January 2003). Intensive Care Medicine. Lippincott
Williams & Wilkins, Philadelphia: pgs. 35-548.
Wung, S., Aouizerat, B. E. (Nov/Dec 2004). Aortic Aneurysms. Journal of
Cardiovascular Nursing. Lippincott Williams & Wilkins, Inc.:19(6):409-416, 34(2).